Masako Ishikawa, Kentaro Nakayama, Sultana Razia, Akiko Ishida, Hitomi Yamashita, Tomoka Ishibashi, Seiya Sato, Kiyoka Sawada, Hiroki Sasamori, Sonomi Kurose, Noriyoshi Ishikawa, Satoru Kyo
BACKGROUND: Neutropenic enterocolitis (NE) is a potentially life-threatening disease that primarily occurs in cancer patients treated with chemotherapy. NE has substantial morbidity and mortality, and its incidence has increased with the widespread use of chemotherapeutic agents such as taxanes, gemcitabine, and leucovorin in patients with lung, breast, gastric, and ovarian cancers. Sometimes NE can be a possible cause of death. Although, conservative approaches are often successful, there are currently no standardized treatment guidelines for NE and it is unclear when such strategies should be implemented...
May 3, 2021: BMC Women's Health